KKR and Warburg Pincus are among those said to be exploring a $10bn plan to buy hundreds of older drug brands from GSK and Sanofi and merge them
Source: Companies
Author
Harry Joiner
“… a dominant recruiter in the client-side multichannel ecommerce space …” — SearchEngineWatch.com